First Wave BioPharma Price Prediction

FWBIDelisted Stock  USD 0.61  0.03  4.69%   
As of 29th of November 2024, the value of RSI of First Wave's share price is approaching 39. This usually indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling First Wave, making its price go up or down.

Oversold Vs Overbought

39

 
Oversold
 
Overbought
The successful prediction of First Wave's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with First Wave BioPharma, which may create opportunities for some arbitrage if properly timed.
Using First Wave hype-based prediction, you can estimate the value of First Wave BioPharma from the perspective of First Wave response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in First Wave to buy its stock at a price that has no basis in reality. In that case, they are not buying First because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

First Wave after-hype prediction price

    
  USD 0.61  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Intrinsic
Valuation
LowRealHigh
0.580.580.67
Details
Naive
Forecast
LowNextHigh
0.360.360.36
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.580.650.72
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as First Wave. Your research has to be compared to or analyzed against First Wave's peers to derive any actionable benefits. When done correctly, First Wave's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in First Wave BioPharma.

First Wave After-Hype Price Prediction Density Analysis

As far as predicting the price of First Wave at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in First Wave or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of First Wave, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

First Wave Estimiated After-Hype Price Volatility

In the context of predicting First Wave's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on First Wave's historical news coverage. First Wave's after-hype downside and upside margins for the prediction period are 0.61 and 0.61, respectively. We have considered First Wave's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.61
0.61
After-hype Price
0.61
Upside
First Wave is very steady at this time. Analysis and calculation of next after-hype price of First Wave BioPharma is based on 3 months time horizon.

First Wave Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as First Wave is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading First Wave backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with First Wave, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
12 Events / Month
In a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.61
0.61
0.00 
0.00  
Notes

First Wave Hype Timeline

First Wave BioPharma is currently traded for 0.61. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. First is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on First Wave is about 0.0%, with the expected price after the next announcement by competition of 0.61. The company has price-to-book (P/B) ratio of 1.87. Some equities with similar Price to Book (P/B) outperform the market in the long run. First Wave BioPharma recorded a loss per share of 47.88. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 18th of December 2023. Given the investment horizon of 90 days the next forecasted press release will be in a few days.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

First Wave Related Hype Analysis

Having access to credible news sources related to First Wave's direct competition is more important than ever and may enhance your ability to predict First Wave's future price movements. Getting to know how First Wave's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how First Wave may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
QNRXQuoin Pharmaceuticals Ltd(0.01)11 per month 6.66  0.03  17.65 (9.68) 74.46 
BWVBWV(0.01)2 per month 2.98  0.02  4.26 (4.72) 68.28 
PXMDPaxMedica, Common Stock 0.00 0 per month 0.00 (0.23) 7.63 (7.28) 23.71 
REVBRevelation Biosciences(0.03)3 per month 0.00 (0.11) 8.97 (7.83) 34.52 
HILSHillstream Biopharma 0.03 3 per month 0.00 (0.06) 8.33 (7.89) 113.15 
DRMADermata Therapeutics 0.04 3 per month 0.00 (0.06) 9.22 (8.05) 69.06 
PBLAPanbela Therapeutics 0.00 0 per month 0.00 (0.21) 10.70 (17.30) 88.58 
CFRXContraFect Corp 0.01 1 per month 0.00 (0.04) 12.23 (8.45) 55.69 
ICULMF Acquisition Opportunities(0.12)12 per month 0.00 (0.21) 7.98 (6.93) 31.31 
VIRIVirios Therapeutics Llc 0.14 5 per month 0.00 (0.05) 12.46 (10.62) 50.54 
ZVSAZyVersa Therapeutics(0.1)4 per month 0.00 (0.16) 7.57 (9.60) 78.93 
SONNSonnet Biotherapeutics Holdings 1.15 6 per month 0.00 (0.17) 12.31 (9.79) 37.58 
CDIOCardio Diagnostics Holdings(0.01)3 per month 6.78 (0.01) 14.81 (13.16) 57.04 
SGTXSigilon Therapeutics(5.67)8 per month 6.43  0.11  12.46 (14.07) 442.39 
XFORX4 Pharmaceuticals 0.02 8 per month 0.00 (0.04) 8.82 (10.61) 62.35 
ZURAZura Bio Limited(0.21)9 per month 0.00 (0.11) 7.95 (7.94) 26.70 
APGNApexigen(0.02)5 per month 5.50 (0) 7.89 (11.11) 58.79 
PHIOPhio Pharmaceuticals Corp(0.01)6 per month 0.00 (0.03) 11.78 (10.38) 36.22 
EFTREffector Therapeutics(0.06)4 per month 0.00 (0.31) 8.70 (27.78) 88.91 
IMMXImmix Biopharma(0.04)4 per month 4.55 (0.02) 9.38 (8.22) 32.68 

First Wave Additional Predictive Modules

Most predictive techniques to examine First price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for First using various technical indicators. When you analyze First charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About First Wave Predictive Indicators

The successful prediction of First Wave stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as First Wave BioPharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of First Wave based on analysis of First Wave hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to First Wave's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to First Wave's related companies.

Story Coverage note for First Wave

The number of cover stories for First Wave depends on current market conditions and First Wave's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that First Wave is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about First Wave's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

First Wave Short Properties

First Wave's future price predictability will typically decrease when First Wave's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of First Wave BioPharma often depends not only on the future outlook of the potential First Wave's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. First Wave's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding336.3 K
Cash And Short Term Investments3.7 M
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Consideration for investing in First Stock

If you are still planning to invest in First Wave BioPharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the First Wave's history and understand the potential risks before investing.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account